Cat: IPD-X41206

Recombinant Mouse Chi3l4 Protein (Yeast),His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    Chi3l4

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    Chitinase-3-like protein 4 Secreted protein Ym2

  • 种属

    Mouse

  • 表达系统

    Yeast

  • 标签

    N- His

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q91Z98

  • 表达区间

    22-402aa

  • 分子量

    44.9

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Chi3l4, also known as chitinase-3-like protein 4, is a member of the chitinase-like protein family, which plays a critical role in various biological processes, including inflammation, tissue remodeling, and immune response. Originally identified as an eosinophil-associated protein, Chi3l4 is primarily expressed in immune cells and is thought to participate in the regulation of allergic reactions and responses to parasitic infections. Recent studies have highlighted its role in several disease states, including asthma, cancer, and cardiovascular diseases, suggesting that Chi3l4 may serve as a potential biomarker for disease progression and a target for therapeutic intervention. The protein is believed to influence the immune landscape by modulating the activities of various immune cells, thereby affecting inflammation and tissue homeostasis. As research continues to unveil the functional implications of Chi3l4, understanding its expression patterns and mechanisms may provide insights into the development of targeted therapies for conditions where inflammation and immune dysregulation are pivotal. The focus on Chi3l4 in recent years underscores its significance in both basic and translational research, specifically in the context of its potential to inform the design of novel diagnostic and therapeutic strategies for immune-related diseases. Thus, the study of Chi3l4 recombinant proteins aims to elucidate their biological functions, therapeutic applications, and mechanisms of action, thereby contributing to the broader field of immunology and disease treatment strategies.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US